(Finance) – The ordinary and extraordinary meeting of Elesa company listed on Euronext Growth Milan and global supplier of solutions for testing semiconductor devices (IC Integrated Circuits) with Automotive and Mission Critical applications, has approved the financial statements as of 31 December 2023, as approved and presented by the Board of Administration, which reports an operating profit of Euro 92,400.00.
Upon proposal of the Board of Directors, the Assembly also resolved to allocate the operating profit of Euro 4,620.00 to the legal reserve; for Euro 87,780.00 to extraordinary reserve.
During the Assembly, the Group’s Consolidated Financial Statements for the 2023 financial year were also presented, which close with a positive net result pertaining to the Eles Group of Euro 799,465.64.
The ordinary Shareholders’ Meeting approved the authorization for the purchase, even in several tranches, within 18 months from the date of the resolution, of Company shares without par value, up to a maximum number which, taking into account the shares of the company from time to time held in the company’s portfolio, does not overall exceed one fifth of the share capital (equal to Euro 1,446,688.8, represented by 3,524,777 shares) and in any case for a maximum value of Euro 1,000 ,000.00, for the pursuit of the purposes set out in the Explanatory Report of the Board of Directors, subject to revocation of the previous authorization granted by the Ordinary Shareholders’ Meeting of the Company on 14 June 2023, which remained unexecuted.
The Assembly also authorized the Board of Directors to dispose, in whole or in part, on one or more occasions, of the treasury shares purchased.